Figure 1From: Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient’s outcome in advanced colorectal cancer: the CORIOLAN study Study design. TTP = time to progression, SUV = Standardized Uptake Value; TLG = Total Lesion Glycolysis, mCRC = metastatic ColoRectal Cancer, FDG-PET: FluoroDeoxyGlucose-Positron Emission Tomography, DW-MRI = Diffusion-Weighted Magnetic Resonance Imaging, CTC: Circulating Tumor Cells).Back to article page